Publication:
Impact of the Timing of Metoprolol Administration During STEMI on Infarct Size and Ventricular Function

dc.contributor.authorGarcia-Ruiz, Jose M
dc.contributor.authorFernandez-Jimenez, Rodrigo
dc.contributor.authorGarcia-Alvarez, Ana
dc.contributor.authorPizarro, Gonzalo
dc.contributor.authorGalan-Arriola, Carlos
dc.contributor.authorFernandez-Friera, Leticia
dc.contributor.authorMateos, Alonso
dc.contributor.authorNuno-Ayala, Mario
dc.contributor.authorAguero, Jaume
dc.contributor.authorSanchez-Gonzalez, Javier
dc.contributor.authorGarcia-Prieto, Jaime
dc.contributor.authorLopez-Melgar, Beatriz
dc.contributor.authorMartinez-Tenorio, Pedro
dc.contributor.authorLopez-Martin, Gonzalo J.
dc.contributor.authorMacias, Angel
dc.contributor.authorPerez-Asenjo, Braulio
dc.contributor.authorCabrera, José Ángel
dc.contributor.authorFernandez-Ortiz, Antonio
dc.contributor.authorFuster, Valentin
dc.contributor.authorIbáñez, Borja
dc.date.accessioned2017-10-30T13:15:46Z
dc.date.available2017-10-30T13:15:46Z
dc.date.issued2016
dc.description.abstractBACKGROUND Pre-reperfusion administration of intravenous (IV) metoprolol reduces infarct size in ST-segment elevation myocardial infarction (STEMI). OBJECTIVES This study sought to determine how this cardioprotective effect is influenced by the timing of metoprolol therapy having either a long or short metoprolol bolus-to-reperfusion interval. METHODS We performed a post hoc analysis of the METOCARD-CNIC (effect of METOprolol of CARDioproteCtioN during an acute myocardial InfarCtion) trial, which randomized anterior STEMI patients to IV metoprolol or control before mechanical reperfusion. Treated patients were divided into short-and long-interval groups, split by the median time from 15 mg metoprolol bolus to reperfusion. We also performed a controlled validation study in 51 pigs subjected to 45 min ischemia/reperfusion. Pigs were allocated to IV metoprolol with a long (-25 min) or short (-5 min) pre-perfusion interval, IV metoprolol post-reperfusion (+60 min), or IV vehicle. Cardiac magnetic resonance (CMR) was performed in the acute and chronic phases in both clinical and experimental settings. RESULTS For 218 patients (105 receiving IV metoprolol), the median time from 15 mg metoprolol bolus to reperfusion was 53 min. Compared with patients in the short-interval group, those with longer metoprolol exposure had smaller infarcts (22.9 g vs. 28.1 g; p = 0.06) and higher left ventricular ejection fraction (LVEF) (48.3\% vs. 43.9\%; p = 0.019) on day 5 CMR. These differences occurred despite total ischemic time being significantly longer in the long-interval group (214 min vs. 160 min; p < 0.001). There was no between-group difference in the time from symptom onset to metoprolol bolus. In the animal study, the long-interval group (IV metoprolol 25 min before reperfusion) had the smallest infarcts (day 7 CMR) and highest long-term LVEF (day 45 CMR). CONCLUSIONS In anterior STEMI patients undergoing primary angioplasty, the sooner IV metoprolol is administered in the course of infarction, the smaller the infarct and the higher the LVEF. These hypothesis-generating clinical data are supported by a dedicated experimental large animal study. (C) 2016 by the American College of Cardiology Foundation.
dc.description.peerreviewed
dc.description.sponsorshipThe authors thank Noemi Escalera and Maite Rodriguez, who were outstanding in the management of the clinical trial and imaging analyses. The authors are also indebted to the generous dedication of time and effort to the METOCARD-CNIC trial by all coinvestigators from SUMMA112, 061 Galicia, and SAMUR. The coordinating center at SCU-SUMMA112 was crucial for the proper conduct of the trial. Tamara Cordoba, Oscar Sanz, Ruben Mota, Santiago Rodriguez, Eugenio Fernández, and the rest of the team at the CNIC Animal Facility and farm provided outstanding animal care and support. Simon Bartlett (CNIC) provided English editing.
dc.format.page2093-2104
dc.format.volume67
dc.identifierISI:000375406100001
dc.identifier.citationJ Am Coll Cardiol. 2016; 67(18):2093-2104
dc.identifier.doi10.1016/j.jacc.2016.02.050
dc.identifier.e-issn1558-3597
dc.identifier.issn0735-1097
dc.identifier.journalJournal of the American College of Cardiology
dc.identifier.pubmedID27052688
dc.identifier.urihttp://hdl.handle.net/20.500.12105/5231
dc.language.isoeng
dc.publisherElsevier
dc.relation.publisherversionhttps://doi.org/10.1016/j.jacc.2016.02.050
dc.repisalud.institucionCNIC
dc.repisalud.orgCNICCNIC::Grupos de investigación::Laboratorio Traslacional para la Imagen y Terapia Cardiovascular
dc.repisalud.orgCNICCNIC::Grupos de investigación::Imagen Cardiovascular y Estudios Poblacionales
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectACUTE MYOCARDIAL-INFARCTION
dc.subjectST-SEGMENT-ELEVATION
dc.subjectPERCUTANEOUS CORONARY INTERVENTION
dc.subject2013 ACCF/AHA GUIDELINE
dc.subjectASSOCIATION TASK-FORCE
dc.subjectMETOCARD-CNIC TRIAL
dc.subjectCLINICAL-TRIAL
dc.subjectBETA-BLOCKERS
dc.subjectISCHEMIA/REPERFUSION
dc.subjectCARDIOPROTECTION
dc.titleImpact of the Timing of Metoprolol Administration During STEMI on Infarct Size and Ventricular Function
dc.typejournal article
dc.type.hasVersionVoR
dspace.entity.typePublication
relation.isAuthorOfPublicationf8bdc86d-5800-41d9-865a-bf567a8acf9f
relation.isAuthorOfPublicationa6bead57-638c-4bc1-96de-94d972aa3e2c
relation.isAuthorOfPublication92018446-2b00-4798-a27d-d2b26871b81b
relation.isAuthorOfPublicationfd09339f-c3f0-46dd-8e0f-d2d60f267dfe
relation.isAuthorOfPublication7a3eb52c-08fc-474a-8bca-e069339a4bc6
relation.isAuthorOfPublication4b2a0672-e9a0-4788-b256-d3170c84aab2
relation.isAuthorOfPublicationa93dc37a-5639-4e82-bbdc-9880ba529dbd
relation.isAuthorOfPublicationb1b3c0d9-ef50-4419-8b55-e13c08806181
relation.isAuthorOfPublicationb6428aa3-d242-4efb-a7a2-b977c3aeadd8
relation.isAuthorOfPublicationdd06e43e-9ba0-4760-ae40-a3c757f06289
relation.isAuthorOfPublicatione0026bba-db67-4a42-8fa8-79005fe4857e
relation.isAuthorOfPublication626bd700-c4dc-44c4-8849-c1ac5ffbc7a3
relation.isAuthorOfPublication890bb41c-f97f-4d81-8c1e-c22e247d3d66
relation.isAuthorOfPublicationcde7175c-b260-427b-86cd-2b34d6772014
relation.isAuthorOfPublicationc247543c-ab71-441c-8eec-b54f56c6a1ff
relation.isAuthorOfPublication558474d4-85be-4127-bda8-59128f707249
relation.isAuthorOfPublication2cac8bb6-2bff-4bf6-8209-bdbd21781786
relation.isAuthorOfPublication.latestForDiscoveryf8bdc86d-5800-41d9-865a-bf567a8acf9f

Files

Original bundle

Now showing 1 - 2 of 2
Loading...
Thumbnail Image
Name:
ImpactOfTheTimingOfMetoprololAdministration_2016
Size:
808.76 KB
Format:
Adobe Portable Document Format
Loading...
Thumbnail Image
Name:
ImpactOfTheTimingOfMetoprololAdministration_2016_AppendixTable.pdf
Size:
255.21 KB
Format:
Adobe Portable Document Format